Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cedirian

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annales De Dermatologie Et De Venereologie|October 9, 2023
Self-induced nail disorders (SINDs): What do we know so far?M Starace, S Cedirian, A Alessandrini, et al.
Journal of Cosmetic Dermatology|July 7, 2023
Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopeciaS Cedirian, F Bruni, F Quadrelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annales De Dermatologie Et De Venereologie|October 9, 2023
Self-induced nail disorders (SINDs): What do we know so far?M Starace, S Cedirian, A Alessandrini, et al.
Journal of Cosmetic Dermatology|July 7, 2023
Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopeciaS Cedirian, F Bruni, F Quadrelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 1